Search results
Results from the WOW.Com Content Network
[28] [29] IMS Health shareholders received 0.384 shares of Quintiles common stock for each share of IMS Health common stock they held, leaving the split of ownership at 51.4% IMS and 48.6% Quintiles. [ 30 ] [ 31 ] The merger was completed in October and the resulting company was a $17.6 billion company called QuintilesIMS. [ 9 ]
IMS stood for Intercontinental Medical Statistics. It was the largest vendor of U.S. physician prescribing data. [2] [3] [4] IMS Health was founded in 1954 by Bill Frohlich and David Dubow with Arthur Sackler having a hidden ownership stake. [5] In 2010, IMS Health was taken private by TPG Capital, CPP Investment Board and Leonard Green ...
In 2008, he became director of Quintiles Transnational Corp, a healthcare company in the field of clinical research. [5] In 2016, Quintiles merged with IMS Health, a health IT company, to become IQVIA. Connaughton became a director of IQVIA in October of that year. [5] Connaughton was appointed to the board of HCA Healthcare for a term through ...
Xu Jiapeng, an account manager at Quintiles IMS in Beijing, said it was "unthinkable" China operated a clandestine system that the data on immunosuppressants did not pick up. [ 8 ] However, according to a 2020 report by the US government–affiliated Victims of Communism Memorial Foundation (VOC), a group of experts pointed out that the Post ...
In 1994, he took Quintiles public through an IPO. [6] Quintiles is the "largest global provider of clinical trials and commercial marketing services to the pharmaceutical and biotechnology industry". [5] In December 2015, Gillings retired as executive chairman of Quintiles, but remains a director. [6]
Its new name maintains parts of its original formation, with the ‘I’ representing IMS and the ‘Q’ taken from Quintiles. However, the latter and newest part of the name - ‘via’ - is representative of “seeking to inspire and ignite real change via a new path forward”, explains Ari Bousbib, chief executive officer of IQVIA."
From Wikipedia, the free encyclopedia. Redirect page
However, in the mid-1990s the industry, through third-party prescribing data (e.g., Quintiles/IMS) switched to "script-tracking" [10] technologies, measuring the number of total prescriptions (TRx) and new prescriptions (NRx) per week that each physician writes. This information is collected by commercial vendors.